Rachel Vaknin
Chief Financial OfficerMs. Rachel Vaknin serves as Chief Financial Officer at Microbot Medical Inc. since April 01, 2022. Ms. Vaknin is responsible for the Microbot Medical’s global finance, including financial planning and analysis, investor relations and tax. Prior to that, she was the Chief Financial Officer of Imagry, an Israeli-American autonomous technologies software provider, from September 2017 to December 2021. Ms. Vaknin joined Microbot Medical Inc. in January 2022 as VP of Finance. Prior to joining Microbot Medical, she was the CFO for a company in the autonomous driving sector and some of her primary duties included budget planning and forecasts, preparation for financial due diligences and fundraising. From April 2004 to December 2016, Ms. Vaknin was the FP&A Department Manager at Mellanox Technologies Ltd., an Israeli-American multinational supplier of computer networking products acquired by Nvidia in 2020, where she was responsible, among other things, for budget planning, budget control, building and maintaining business intelligence key performance indicators, leading teams with respect to preparing quarterly financial statements, obtaining and managing grant monies and Sarbanes-Oxley controls. She worked at BDO – Ziv & Haft, a leading worldwide accounting firm.
公司職務
- 公司名稱Microbot Medical Inc.股票代碼MBOT職務Chief Financial Officer共事同僚
- HGHarel GadotCo-Founder, President, CEO & Chairman
- SSSimon SharonCTO & GM of Microbot Israel
- JDJuan Diaz-CartelleChief Medical Officer
- CBChristina BaileyVice President of Sales
- SRScott R. BurellIndependent Director
- MJMartin J. MaddenIndependent Director
- PLPrattipati LaxminarainIndependent Director
- EMEyal MoragMember of Scientific Advisory Board
